Peregrine Pharmaceuticals Provides Corporate Update Highlighting Latest Developments for Contract Manufacturing and Drug Development Businesses
June 02, 2016 08:05 ET | Peregrine Pharmaceuticals Inc.
- Contract Manufacturing Revenue Hits All-Time High of $44 Million for Fiscal Year Ended April 2016; Fiscal Year 2017 Contract Manufacturing Revenue Projected Between $50-55 Million; Continued...
Peregrine Pharmaceuticals Announces Formal Commissioning of New, State-of-the-Art Commercial Manufacturing Facility
March 07, 2016 08:05 ET | Peregrine Pharmaceuticals Inc.
TUSTIN, Calif., March 07, 2016 (GLOBE NEWSWIRE) -- Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) (NASDAQ:PPHMP), a biopharmaceutical company focused on developing therapeutics to stimulate the...
Avid Bioservices Highlights New Bioassay Capabilities to Support Phase III and Commercial-Stage Development Programs
May 14, 2013 11:00 ET | Avid Bioservices
TUSTIN, CA--(Marketwired - May 14, 2013) - Avid Bioservices, Inc., a wholly owned subsidiary of Peregrine Pharmaceuticals, Inc., today announced that its recent success in qualifying an...
Avid Bioservices to Present a Case Study on cGMP Production Scale-Up, Optimization and Transition From a Stainless Steel to a Fully Disposable Process at BIO International Convention
April 19, 2013 13:00 ET | Avid Bioservices
TUSTIN, CA--(Marketwired - Apr 19, 2013) - Avid Bioservices, Inc., a subsidiary of Peregrine Pharmaceuticals, Inc., today announced its upcoming participation at the Biotechnology Industry...
Avid Bioservices to Highlight Recent Successes in Reducing Manufacturing Costs and Novel Ways of Controlling Critical Process Parameters That Lead to Consistent Product Quality at IBC'S Biopharmaceutical Development and Production Conference
February 26, 2013 15:20 ET | Avid Bioservices
TUSTIN, CA and HUNTINGTON BEACH, CA--(Marketwire - Feb 26, 2013) - Avid Bioservices, Inc., a subsidiary of Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM), today announced that it will present two...
Avid Bioservices Announces Completion of Facility Upgrades in Response to Increased Demand for Its Contract Manufacturing Services
December 13, 2012 11:00 ET | Avid Bioservices
TUSTIN, CA--(Marketwire - Dec 13, 2012) - Avid Bioservices, Inc, a contract manufacturing organization (CMO) focused on the process development and manufacturing of monoclonal antibodies, proteins...
Advanced BioScience Laboratories Awards Avid Bioservices HIV Vaccine Development and Manufacturing Contract
September 27, 2012 08:00 ET | Avid Bioservices
TUSTIN, CA, and ROCKVILLE, MD--(Marketwire - Sep 27, 2012) - Avid Bioservices, a subsidiary of Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM), today announced that it has been chosen by Advanced...
Avid Bioservices Announces Addition of Novel Bacteriophage Production System at Upcoming BIO Conference as Part of a Collaboration With Phage Pharmaceuticals
June 11, 2012 16:30 ET | Avid Bioservices
TUSTIN, CA--(Marketwire - Jun 11, 2012) - Avid Bioservices, a subsidiary of Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM), today announced that it will collaborate with San Diego-based Phage...
AVID Bioservices Highlights Antibody Engineering, Expression and Bioassay Expertise at AACR
April 02, 2012 16:00 ET | Avid Bioservices
TUSTIN, CA--(Marketwire - Apr 2, 2012) - Avid Bioservices, a subsidiary of Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM), today presented data at the Annual Meeting of the American Association of...
Avid Bioservices to Present at IBC's Antibody Development and Production Conference
February 23, 2012 16:00 ET | Avid Bioservices
TUSTIN, CA and SAN DIEGO, CA--(Marketwire - Feb 23, 2012) - Avid Bioservices, Inc., a leading provider of integrated biomanufacturing services and a subsidiary of Peregrine Pharmaceuticals, Inc....